We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+4.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.04B
AUM Growth
+$73M
(+1.2%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-2.38%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
1,047
New
173
Increased
233
Reduced
390
Closed
225
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$50M |
| 2 |
Merck
MRK
|
+$46.7M |
| 3 |
Cognizant
CTSH
|
+$37.2M |
| 4 |
Las Vegas Sands
LVS
|
+$25.6M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$51.6M |
| 2 |
Comcast
CMCSA
|
+$48.7M |
| 3 |
Intel
INTC
|
+$38.4M |
| 4 |
Amazon
AMZN
|
+$38.4M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
+$36.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.81% |
| 2 | Industrials | 13.63% |
| 3 | Financials | 13.56% |
| 4 | Healthcare | 12.66% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Selective Insurance
SIGI
$5.74B
| $4.1M | 0.07% |
165,681
-12,800
| -7% | -$302K |
|
302
Quad
QUAD
$430M
| $4.05M | 0.07% |
181,187
+48,100
| +36% | +$1.03M |
|
|
SIMG
303
DELISTED
SILICON IMAGE INC
SIMG
| $3.98M | 0.07% |
789,802
-65,800
| -8% | -$371K |
|
304
Calix
CALX
$2.27B
| $3.94M | 0.07% |
481,127
-3,900
| -0.8% | -$31.9K |
|
|
KRA
305
DELISTED
Kraton Corporation
KRA
| $3.93M | 0.07% |
175,643
+8,460
| +5% | +$217K |
|
306
Brady Corp
BRC
$4.45B
| $3.85M | 0.06% |
128,975
+54,815
| +74% | +$1.47M |
|
307
ConocoPhillips
COP
$147B
| $3.84M | 0.06% |
44,820
-6,900
| -13% | -$538K |
|
|
SPTN
308
DELISTED
SpartanNash
SPTN
| $3.81M | 0.06% |
181,183
+130,845
| +260% | +$2.91M |
|
|
INFN
309
DELISTED
Infinera Corporation Common Stock
INFN
| $3.8M | 0.06% |
413,001
-124,500
| -23% | -$1.11M |
|
310
Nektar Therapeutics
NKTR
$2.39B
| $3.76M | 0.06% |
+19,559
| New | +$3.46M |
|
311
APA Corp
APA
$12.8B
| $3.74M | 0.06% |
+37,180
| New | +$3.37M |
|
|
KND
312
DELISTED
Kindred Healthcare
KND
| $3.74M | 0.06% |
161,827
+67,450
| +71% | +$1.65M |
|
313
Cummins
CMI
$91.7B
| $3.71M | 0.06% |
24,010
+21,490
| +853% | +$3.25M |
|
|
I
314
DELISTED
INTELSAT S. A.
I
| $3.69M | 0.06% |
195,721
+151,801
| +346% | +$2.82M |
|
315
LXP Industrial Trust
LXP
$3.53B
| $3.65M | 0.06% |
+66,368
| New | +$3.68M |
|
316
PBF Energy
PBF
$7.29B
| $3.64M | 0.06% |
+136,720
| New | +$4.04M |
|
|
CEB
317
DELISTED
CEB Inc.
CEB
| $3.62M | 0.06% |
+53,106
| New | +$3.65M |
|
318
Emergent Biosolutions
EBS
$375M
| $3.62M | 0.06% |
161,243
-21,000
| -12% | -$489K |
|
319
The Mosaic Company
MOS
$7.09B
| $3.6M | 0.06% |
+72,800
| New | +$3.59M |
|
320
Cabot Corp
CBT
$4.65B
| $3.6M | 0.06% |
+62,031
| New | +$3.61M |
|
321
Edison International
EIX
$30.7B
| $3.58M | 0.06% |
61,560
+33,100
| +116% | +$1.85M |
|
|
CSGS
322
DELISTED
CSG Systems International
CSGS
| $3.56M | 0.06% |
136,267
-6,500
| -5% | -$169K |
|
|
PPL
323
PPL Corp
PPL
$27.3B
| $3.5M | 0.06% |
+105,779
| New | +$3.33M |
|
|
RKT
324
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $3.5M | 0.06% |
66,298
-18,270
| -22% | -$920K |
|
|
ASNA
325
DELISTED
Ascena Retail Group, Inc.
ASNA
| $3.49M | 0.06% |
10,216
-1,855
| -15% | -$634K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2014 Portfolio in Review
As of Q2 2014, Jacobs Levy Equity Management held 1,047 positions worth $6.04B, up 1.2% from $5.97B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q2 2014 filing shows 173 new, 233 increased, 390 reduced and 225 closed positions. Its largest new stake was Merck: 856,750 shares worth $47.3M. The largest sale was DIRECTV COM STK (DE), an estimated $51.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.
- Jacobs Levy Equity Management's largest Q2 2014 buy was Merck: 856,750 shares worth $47.3M.
- Jacobs Levy Equity Management added most to Pfizer in Q2 2014, an estimated $50M increase.
- Jacobs Levy Equity Management's biggest Q2 2014 reduction was Comcast, cutting an estimated $48.7M.
- Jacobs Levy Equity Management fully exited DIRECTV COM STK (DE) in Q2 2014, selling an estimated $51.6M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $6.04B portfolio in Q2 2014.
- Jacobs Levy Equity Management opened 173 new positions and closed 225 in Q2 2014.
- Jacobs Levy Equity Management's portfolio value rose 1.2% quarter-over-quarter to $6.04B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2014, filed 14 Aug 2014.